- $1.05m
- $9.58m
- $4.35m
Brief: ProPhase Labs Reports Special Cash Dividend
Brief: ProPhase Labs Inc Says Testing Volumes Exceeded Well Over 300,000 PCR Covid-19 Tests During Q4 2021
Brief: Prophase Labs Entered Into Sales Agreement With Thinkequity
Brief: Prophase Labs Announces Q3 Loss Per Share Of $0.26
Prophase Labs Inc expected to post earnings of 7 cents a share - Earnings Preview
Brief: ProPhase Labs Files For Mixed Shelf Of Up To $300 Mln
Brief: Prophase Labs Inc Expects Its Q3 2021 COVID-19 Testing Revenues To Be Lower Than Its Q2 2021 Testing Revenues
U.S. STOCKS ON THE MOVE-Ford, Genius Sports, GameStop
ProPhase Labs rises on share buyback plan
Brief: Prophase Labs Announces $6 Mln Stock Repurchase Program
Brief: Prophase Labs Announces Financial Results For The Quarter Ended June 30, 2021
Brief: ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics
Prophase Labs Inc expected to post earnings of 34 cents a share - Earnings Preview
Prophase Labs Inc expected to post earnings of 34 cents a share - Earnings Preview
Brief: Prophase Labs Diversifies With Formation Of Genomics And Global Healthcare Subsidiaries
Brief: Prophase Labs Reports First Quarter 2021 Financial Results And Announces $0.30 Special Cash Dividend
Prophase Labs Inc expected to post earnings of 21 cents a share - Earnings Preview
Brief: Prophase Labs Partners With Dutchess County New York To Provide COVID-19 Testing
Brief: ProPhase Labs Inc To Provide Covid-19 Testing For Oyster Bay Township In New York